Phreesia, Inc. (NYSE:PHR) Director Michael Weintraub Sells 861 Shares

Phreesia, Inc. (NYSE:PHR) Director Michael Weintraub sold 861 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $25.26, for a total transaction of $21,748.86. Following the completion of the transaction, the director now owns 242,827 shares in the company, valued at approximately $6,133,810.02. This represents a 0.35 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Michael Weintraub also recently made the following trade(s):

• On Friday, December 13th, Michael Weintraub sold 20,565 shares of Phreesia stock. The shares were sold at an average price of $25.04, for a total transaction of $514,947.60.
• On Monday, December 2nd, Michael Weintraub sold 15,152 shares of Phreesia stock. The shares were sold at an average price of $21.01, for a total transaction of $318,343.52.

Phreesia Stock Performance

PHR opened at $23.84 on Friday. The stock has a market capitalization of $1.39 billion, a price-to-earnings ratio of -16.22 and a beta of 0.98. The company has a fifty day moving average of $20.73 and a 200 day moving average of $21.91. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. The company had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. Phreesia’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the company posted ($0.58) earnings per share. As a group, sell-side analysts forecast that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on PHR. Truist Financial increased their price objective on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Robert W. Baird reduced their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $23.00 target price on shares of Phreesia in a report on Friday, September 27th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Phreesia has an average rating of “Moderate Buy” and a consensus price target of $29.33.

Hedge Funds Weigh In On Phreesia

Several institutional investors have recently bought and sold shares of the business. Trust Point Inc. lifted its position in Phreesia by 3.5% during the third quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock valued at $408,000 after purchasing an additional 607 shares during the last quarter. Ensign Peak Advisors Inc lifted its holdings in shares of Phreesia by 3.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after acquiring an additional 700 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Phreesia by 1.0% in the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after acquiring an additional 853 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Phreesia by 3.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock worth $637,000 after acquiring an additional 905 shares during the last quarter. Finally, MetLife Investment Management LLC lifted its holdings in shares of Phreesia by 3.8% in the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock worth $701,000 after acquiring an additional 1,120 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.